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The specificity  of antibody formed in response to an antigenic challenge is a function 
of both the nature of the antigenic determinants used and the genetic capacity of the 
animal to differentiate among and respond to those determinants. At present neither 
the mechanism of specific antigen recognition nor the nature of its genetic control is 
well understood. 
It is widely held that the immunologically competent or committed cell is triggered 
by the interaction of antigen with a complementary and stereospecific receptor identi- 
cal  to  the  antibody  subsequently  produced  (1-5).  However,  on  thermodynamic 
grounds, the difference between the binding energies of anti-hapten antibody for those 
hapten-containing compounds which can trigger the cell and for those that cannot is 
small and does not readily account for the disparity between humoral antibody specific- 
ity and the specificity of cells involved in both cellular immunity and secondary anti- 
hapten antibody synthesis (6-13). To account for these differences, several investiga- 
tors have shown that cell cooperation occurs in the secondary anti-hapten antibody 
response between hapten-specific and carrier-specific helper cells (14-17) and that the 
carrier does more than  provide a  complete antigenic determinant for  the  haptenic 
group.  Their experiments indicate that  an interaction between  carrier and  carrier- 
specific helper cell facilitates the triggering of the bone marrow-derived anti-hapten 
antibody-forming cell. Such a mechanism provides a basis for the carrier effect noted in 
triggering the secondary anti-hapten antibody response. But this mechanism implies 
that  the  haptenic  group  by itself constitutes  an  antigenic determinant capable of 
triggering the hapten-specific antibody-forming cell provided that the carrier-specific 
cell "delivers" the antigen to the bone marrow-derived antibody-forming cell, and that 
the anti-hapten antibody receptor on such a  cell possesses sufficient affinity for the 
haptenic group to be triggered. 
A  carrier cell-hapten cell model for antigen recognition and  gene  action is best 
understood  by presuming  that  the  antibody-forming cell has  only limited  carrier 
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specificity. The present studies, utilizing the technique of fluorescence  quenching, were 
undertaken  to  explore  the precise carrier  specificity of anti-hapten  antibody in re- 
sponder and nonresponder guinea pigs. Animals were immunized with a series of singly 
substittued e, dinitrophenyl (DNP) 1  and o~, DNP-oligolysine peptides differing from one 
another only by the addition of several lysyl (Lys) residues to the end of the peptide 
chain furthest from the immunodominant DNP group. These added lysines, situated 
more than seven lysyl residues from the haptenic group, are dearly excluded from any 
previously proposed spatial limits of one antibody-binding site  (6, 9,  18-20). There- 
fore, if  the antibodies produced by immunization with DNP-oligolysines of slightly 
different  chain  lengths  can  recognize  their  homologous antigens,  they  presumably 
would be detecting conformational changes in the portion of the peptide chain adjacent 
to the haptenic group. More important, such a finding would suggest that each DNP- 
oligolysine  compound requires  either a  specific  carrier cell,  a  specific hapten-carrier 
antibody-forming cell, or both. Each alternative requires a much greater number of 
preexisting specific cells than previously estimated, thus diminishing the chance inter- 
action between two or more such specific cells. 
The ability to respond to polylysines or oligolysines is inherited in the guinea pig as 
an autosomal mendelian  dominant trait  (21-24)  and  the polylysine gene has been 
postulated to act at the level of the carrier-specific  cell (24). This locus of gene action 
implies that responder and nonresponder guinea pigs possess  the same group of anti- 
body-forming cells. In support of this hypothesis was the demonstration that DNP- 
oliglysines  in association with an immunogenic carrier  evoke in nonresponder guinea 
pigs the formation of anti-DNP antibody no different from that obtained in responder 
animals under comparable conditions (25). 
In the present  studies  it will be shown that  antibody formed in  responder 
animals  to defined DNP-oligolysines is extraordinarily  specific and capable  of 
recognizing the precise chain length of the DNP-oligolysines used to induce the 
immune response. The antibody-forming cell is then also capable of a fine degree 
of carrier recognition, On the other hand, the anti-DNP antibody generated in 
nonresponder  animals  by immunization  with  DNP-oligolysines in association 
with  a  molecule recognized as immunogenic lacks this  capacity to distingush 
between  different DNP-oligolysines,  suggesting that the polylysine gene may 
act at the level of the antibody-forming cell. 
Materials  and Methods 
Preparation of Hapten-Substituted  Compounds.--Poly, E,N-benzyloxycarbonyl-I.-lysine with 
an average chain length of 11 (n  =  11) was prepared as previously described (26). After the 
blocked polymer  was  dissolved in  dimethylformamide  and  triethylamine,  1-fluoro-2,4-di- 
nitrobenzene  (Eastman  Organic Chemicals, Rochester, N.  Y.) was added. The DNP-oligo- 
lysines were deblocked and the water-soluble peptides were resolved on carboxymethyl  (CM) 
cellulose, yielding a series of o~, DNP-oligolysines ranging in size from a, DNP-Lys~_  to c~, DNP- 
1 Abbreviations used in tills paper: BAC, bromoacetyl-cetlulose; CM, carboxymethyl; DNP, 
dinitrophenyl;  EACA,  ~-aminocaproic acid; HSA, human serum albumin;  PBS, phosphate- 
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Lys15. In addition three mixtures, c~,DNP-LysT_z0,  c~,DNP-Lysl6_30  and a, DNP-Lys30d00 
were pooled. ~x,DNP-Lys.30_100 represents a mixture of large peptides with an upper limit in 
peptide  size  estimated  to  be approximately  100. 
An homologous series of oligolysine peptides containing a single dinitrophenyl substitution 
on  the  E-amino  group  of  the C-terminal lysine was prepared by Yeda,  Rehovot,  Israel  as 
previously described (27). The blocked polymer was deblocked and the peptides separated on 
a  CM-cellulose column into relatively pure populations of oligopeptides ranging in size from 
2, e, DNP-Lys2  to  19, e, DNP-LySlg.  Although fractionation  was  accomplished  with  good 
resolution, it is likely that any single peptide was contaminated with as much as 5% of those 
peptides containing one lysyl residue more or one less (26). 
Human serum albumin (HSA) (Pentex Biochemicals, Kankakee, Ill.) was dinitrophenylated 
with dinitrobenzene sulfonic acid  (Eastman Kodak)  by standard methods  (28).  The DNP- 
HSA to be conjugated with the immunoabsorbant contained approximately 16 DNP groups 
per mole (DNP~HSA), whereas DNP-HSA to be used for quantitative precipitin titers con- 
tained  approximately 25  groups per mole  (DNP~HSA).  2,4,dinitrophenol  was  purchased 
from  Eastman  Kodak  and  recrystallized  twice  before use.  3H-DNP-EACA  was  made  by 
reacting 3H-l-fluoro-2,4-dinitrobenzene (Nuclear Chicago,  Des  Plaines,  Ill.)  with  e-amino- 
caproic acid in dimethyl formamide and purified by preparative thin-layer chromatography 
using Chrom AR sheet-500  (Mallinckrodt Chemical Works,  St.  Louis,  Mo.)  and a  solvent 
system  containing toluene  60,  pyridine  10,  dioxane  10,  and  2-chloroethanol  10.  The  final 
product had a specific activity of 8 Ci/mM. 
Preparation of Immunoabsorbants.--DNP~HSA  was conjugated  to  bromoacetyl-cellulose 
(BAC) (Miles Laboratory, Elkhart, Ind.) by the method of Robbins et al. (29). 
Immunization.--For  antibody-speclficity studies guinea pigs of the National Institutes of 
Health Hartley strain weighing 500-600 g were divided into five groups containing six to nine 
animals each. Five antigens were used for immunization: a, DNP-Lys~.z0; a, DNP-LySl6-30; 
8, e,DNP-Lyss;  10,e,DNP-Lysz0;  and  15,e,DNP-LySlS.  The  antigens  were  dissolved  in 
saline and emulsified in  a  Virtis homogenizer  (Virtis Co.,  Gardiner,  N.  Y.)  with an equal 
volume of Freund's incomplete adjuvant (Difco Laboratories, Inc., Detroit,  Mich.) to which 
had been added  2 mg/ml Mycobacterium tuberculosis H37Ra  (Difco).  Each animal received 
approximately 90 nmole of antigen (as determined by DNP content) in 0.8 ml of the homoge- 
nate distributed among the four footpads.  They were boosted in the neck on the 7th day 
with 30 nmole of the same antigen dissolved in 0.25 ml of saline and emulsified with an equal 
volume of Freund's incomplete adjuvant.  On days  14 and 21  they were skin tested intra- 
dermally with 2.4 nmole of the same antigen in 0.1 ml of saline. Animals with both positive 
Arthus and delayed-type skin tests were bled three times from day 25 to 32 and the serum 
from each group pooled. The responder rate was about 70%. 
A sixth group of 12 NIH Hartley guinea pigs was immunized with an adjuvant containing 
10 mg/ml M. tuberculosis H37Rv (a gift of Dr. B. Benacerraf). Each animal received a  total 
of  90 nmole of  14,e,DNP-LySl4  dissolved in 0.3  ml saline and  emulsified with  an equal 
volume of Freund's incomplete adjuvant containing  10 mg/ml H37Rv.  The emulsion was 
distributed in all four  footpads. A  seventh group of  12 Camm-Hartley guinea pigs  (Carom 
Research Institute,  Inc., Wayne, N.J.) was similarly immunized except that 90 nmole of c~, 
DNP-LySl6-30 was used as the antigen. The responder rate in the Camm-Hartley guinea pigs 
is reported to  be between 20 and 30%  (30). These animals were skin tested at 13 days with 
their respective immunizing compounds as described above, and only animals with definitely 
positive or negative tests were used  for the antibody-specificity studies. Those animals with 
positive skin  tests were  considered  responder animals and  those with negative skin  tests 
nonresponders  (30).  Between  33  and  43  days  after  immunization the  animals were  bled 
by cardiac puncture three times and  the individual sera pooled. 
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with silica cells of  1  cm light path was used for all spectrophotometric determinations. The 
a,DNP-lysine content of these peptides was determined in 0.01 •  sodium phosphate saline 
buffer,  pH  7.0,  at  360 nm  (E360nm  =  16,800).  The  e-DNP-Lysine content  was  similarly 
determined  (E360nm  =  17,400).  The concentration  of purified  anti-DNP  antibody was ob- 
tained at 280 nm El~X,~  =  13.0. 
Quantitative Precipitin Studies.--For  the quantitative precipitin assay 0.5 ml of antiserum 
was added to a  series of 3 ml centrifuge tubes containing known  quantities  of  DNP~HSA. 
The volume was adjusted to 1 ml with saline and the tubes mixed, incubated for 1 hr at 37°C, 
and allowed to stand for 2 days at 4°C with occasional stirring. The precipitates were washed 
twice with 0.7 ml of cold saline and dissolved in 0.75 ml of 0.02 i  sodium lauryl sulfate. The 
absorbances of  the  resulting  solutions were  then  read  in  a  spectrophotometer  at  360  and 
280 nm. The  estimated  contribution  of  the  DNP~HSA  to  the  absorbance  at  280 nm was 
then subtracted from the observed absorbance at 280 nm and the total concentration of anti- 
DNP antibody calculated  (31). 
Purification of Antibody.--The  purification of antibody was carried  out according to  the 
method of Robbins et  al.  (29).  DNP~HSA cellulose was added  to the serum and mixed on 
a 6 rpm rotator for 2 hr at 4°C. The cellulose was centrifuged at 5000 g and washed with chilled 
saline until the supernatant contained no material absorbing at 280 rim. The packed cellulose 
was suspended in 0.1 M dinitrophenol~).01 M phosphate-buffered saline, pH 7.4  (PBS),  incu- 
bated at 37°C for 1 hr, and centrifuged at 5000 g. The yellow supernantant was passed through 
a  small column of Bio-Rad Anion Exchange Resin AG 1  X  8  (20(P400 mesh)  (Calbiochem, 
Los Angeles, Calif.).  Ammonium sulfate 0.3 g/ml was added  to  the colorless antibody-con- 
taining effluent and allowed to stand at 4°C for 18 hr. The purified antibody precipitate was 
redissolved in PBS  and dialyzed exhaustively against PBS for 24 hr. The solution was then 
centrifuged  to  remove precipitated  protein  and  the  concentration  of  antibody  determined 
spectrophotometrically.  Purified  antibody was run in immunoelectrophoresis against rabbit 
anti-whole guinea pig serum and rabbit anti-guinea pig  ~'1 and "Y2 globulins (gift of Dr. Kurt 
Bloch). 
Fluorescence Quenching.--Fluorescence  quenching was carried out according to the method 
of Velick et al. and Eisen (32, 33). Purified antibody was diluted to a concentration of 50 #g/ml 
in PBS. 2 ml of the solution was pipetted into a 3 ml cuvette and varying amounts of DNP- 
Lysines added  in  0.01 ml portions.  The  antibody  solution was excited  at  280 nm,  and  the 
emission spectrum recorded  at  345 nm on  a  Hitachi-Perkin  Elmer  spectrophotofluorimeter 
(Hitachi America Ltd., Indianapolis, Ind.-Perkin-Elmer Corp., Norwalk,  Conn.). All experi- 
ments were  carried  out  at  25°C. 
Of approximately 17 points obtained with each fluorescence quenching titration, 8-10 were 
used  for calculating an  equilibrium constant  (K0).  As has been reported  previously,  initial 
titration points in this technique have a disproportionate amount of quenching, which results 
in negative values for free concentration of hapten, and must be discarded  (33). The value of 
Qmnx was taken as 100% yielding a K0 which did not differ by more than 5% whed compared 
to one obtained with equilibrium dialysis with the same antibody using tritiated DNP-EACA 
or a,DNP-oligolysines. These results are consistent with our previous demonstration of the 
agreement between fluorescence quenching and equilibrium dialysis (6). The  Qmax obtained 
empirically for each antibody ranged between 75 and 80%. 
With the use of a  time-shared PDP-1 computer the 8-10 titration values were converted to 
points on a  Sips plot,  In r/n-r  =  aln K0 +  aln C  (34, 35), where K0 is the equilibrium con- 
stant; a, the index of heterogeneity; and C, the concentration of free hapten. The value of K0 
was obtained and converted to AF  °, the standard free energy, by the formula AF  °  =  -- RT 
In K0. Values for AF  ° had confidence limits at the 0.05 level between 4-150 cal/~,  and dupli- 
cate titration for the same antibody and the same hapten done on different days did not dif- 
fer by more than 100 cal.  AF  ° values differing by more than 200 cal/M were considered signifi- H.  A.  LEVIN,  }I.  LEVINE~  AND  S.  F.  SCIILOSS~AN  1203 
cant. The slopes (a) of the Sips plot (36) for each group of DNP-oligolysines used to examine 
a particular  purified antibody did not differ significantly and were essentially parallel. 
Equilibrium Dialysis.--Equilibrium  dialysis was performed with microdialysis cells (Future 
Plastics,  Cambridge,  Mass.) having  0.1 ml  chambers.  0.08 ml  of antibody  (300#g/ml)  in 
buffer was placed on one side of the membrane and 0.08 ml of labeled oligopeptide solution on 
the other. The cells were rotated at 6 rpm at 37°C for 1 hr and for 18 hr at 25°C. Similar tubes 
containing labeled peptides without  antibody were prepared to insure that equilibrium  was 
achieved.  Portions  of 0.05 ml were obtained  from both sides of the membrane by  syringe 
(Hamilton Co. Inc., Whittier, Cal.) and dissolved in 0.5 ml of NCS  (Nuclear  Chicago). To 
each sample, 10 ml of Spectrofluor (New England  Nuclear Corp., Boston, Mass.) was added 
and the samples counted in a Packard Tri-Carb  liquid scintillation counter  (Packard Instru- 
ment Co., Downer's Grove, Ill.)  (counting  efficiency 55%). 
RESULTS 
Specificity of Anti-DNP-oligolysine Antibody in Responder Guinea pigs.--The 
total precipitable antibody of guinea pig antiserum to a, DNP-Lys7.IO, a, DNP- 
TABLE I 
Titers of Serum Anti-DNP Antibody and Per Cent of Antibody Yield after Purification 
Immunizing antigen  Serum antibody titer  Yield of purified antibody 
(mg/~nl)  (%) 
a, DNP-LysT_10  0.174  85 
a, DNP-LysI6-30  0. 273  66 
8 ,e, DNP-Lyss  0.179  80 
10, e, DNP-Lysl0  0. 262  74 
15,e, DNP-LySl5  0.423  85 
Lys16-30, 8, e, DNP-Lyss, 10, e, DNP-Lysj0, and 15, e, DNP-Lys15 from responder 
animals immunized with Freund's adjuvant containing 2 mg/ml H37Ra ranged 
between 0.174 and 0.423 mg antibody per milliliter  (Table I). Individual serum 
pools were purified and the yield of antibody was between 66 and 85 %  of the 
total precipitable antibody. 
The  binding  energies  (-AF °)  of  a, DNP-Lysn  peptides,  n, e, DNP-Lys~ 
peptides,  DNP-OH,  and  e,DNP-EACA  to purified  guinea pig  anti-a,DNP- 
LysT.10 antibody were obtained by fluorescence quenching (Fig. 1). As is shown, 
there  is  a  progressive  increase  in  --AF  °  with  increasing  chain  length  from 
a, DNP-Lys3 to a,DNP-Lys9 having a maximum of 10,030 cal/~.  Further in- 
crease in oligiolysine chain length to a, DNP-Lys~, a, DNP-Lys15, or a, DNP- 
Lys16-80  resultedin a decrease of at least 1400 cal/M compared with a, DNP-LysT.9. 
It  should  be  emphasized  that  these  --AF  °  have  confidence  limits  at  -4-150 
cal/M at the 0.05 level. Two additional points are of interest. First, as previously 
shown (6, 37), the haptenic group contributed approximately 70% of the total 
binding energy of a, DNP-Lys9 as measured by binding of DNP-OH or DNP- 
EACA, whereas the carrier portion of the DNP-oligolysine peptide can be esti- 1204  ANTIGEN  RECOGNITION  AND  ANTIBODY  SPECIFICITY 
mated  to  contribute the remaining 30%.  Second, 2, e,DNP-Lys2,  7, e,DNP- 
LysT,  and  10, e, DNP-Lysl0 bind significantly better with anti-a, DNP-LysT-10 
antibody than would have been anticipated from the behavior of the haptenic 
group  alone.  It  is  not  clear  whether  the  additional  contribution in  binding 
energy of, for example, 2, e, DNP-Lyse over DNP-EACA in its interaction with 
anti-a,DNP-LysT_xo  antibody  results  from  populations  of  antibody  with  a 
higher  affinity for  2,e,DNP-Lys2  or  the  capacity  of  ~,DNP  oligolysines to 
conform to the a, DNP-LysT-~0 binding site. Although these cross-reactions do 
occur, it is apparent that anti-a, DNP-LysT-lo antibody contains a measurable 
proportion  of  antibody  molecules  with  specificity for  the  homologous  im- 
munizing antigen. 
Fig.  1. Binding energies (--AF °)  of a,DNP-Lysn peptides, n,e,DNP-Lysn peptides, 
DNP-EACA, and DNP-OH obtained with purified anti-a, DNP-Lys7-10  antibody in fluores- 
scence quenching studies. 
Antibody raised  to a,DNP-Lys16-30,  in  contrast,  shows  no progressive in- 
crease in binding energy from a, DNP-Lys, to a, DNP-Lys9 (Fig. 2). The --AF  ° 
for those compounds ranged between 8309  and 8632  cal/M.  More important, 
on  increasing  the  chain  length  beyond  the  nonamer  there  is  a  progressive 
increase  in  --AF  °  reaching  a  maximum  at  a,DNP-Lys16-30  (9706  cal/~t). 
Once again, the maximal --AF  ° obtained is achieved with those peptides used 
to  initiate  the  immune  response.  Dinitrophenol,e,DNP-oligolysines,  and 
DNP-EACA,  on the other hand,  behaved almost identically with both  anti- 
a,DNP-Lys16_30  and a,DNP-LysT_lo antibody. 
The  binding  characteristics  of  antibody  made  to  8,e,DNP-Lyss,  10,e, 
DNP-Lyslo, and 15,e,DNP-Lys1~ are represented in Figs. 3, 4,  and 5 respec- H.  A.  LEVI_N, H.  LEVINE~  AND  S.  F.  SCHLOSSMAN  1205 
Fig.  2. Binding  energies  (--AF  °)  of a,DNP-Lysn  peptides, n,e,DNP-Lys~  peptides, 
DNP-EACA, and DNP-OH obtained with purified anti-o~,  DNP-Lys16.  30 antibody in fluores- 
cence quenching studies. 
Fig.  3.  Binding  energies  (--AF  °)  of a,DNP-Lysn peptides,  n,e,DNP-Lysn peptides, 
DNP-EACA, and DNP-OH obtained with purified anti-8, e,DNP-Lys8 antibody in fluores- 
cence quenching studies. 
tively. Anti-8, e, DNP-Lyss antibody showed maximal binding with 2, ,, DNP- 
Lys2. The  --AF  ° for this interaction was 10,369 cal/~. Lengthening the chain 
to 3, e,DNP-Lys3 and 5, e, DNP-Lys5 resulted  in a  decrease in  --AF  °.  It was 
intriguing to find that the  --AF  ° for 7,e,DNP-Lys~ (8734 cal/M) was 431-587 1206  ANTIGEN RECOGNITION  AND  ANTIBODY  SPECIFICITY 
Fig.  4.  Binding  energies  (--AF  °)  of o~,  DNP-Lysn  peptides,  n,e,DNP-Lysn  peptides, 
DNP-EACA, and DNP-OH obtained with purified anti-10, ~, DNP-Lysl0 antibody in fluores- 
cence quenching studies. 
Fig.  5.  Binding  energies  (-AF °)  of  a,DNP-Lysn  peptides,  n,e,DNP-Lysn  peptides, 
DNP-EACA, and DNP-OH obtained with purified anti-15, ~, DNP-Lys16 antibody in fluores- 
cence quenching studies. 
cal/~ greater than that found with 5, ~, DNP-Lys5 or 8, ~, DNP-Lys8. Quench- 
ing  with  larger  ~, DNP-oligolysines  resulted  in no  significant  increase  in bind- 
ing energy.  For example, 9, ~,DNP-Lys9  to  15, ~, DNP-Lys15 had  --AF ° rang- 
ing between 8366  and 8482  cal/M,  whereas  the heptamer had  a  --AF ° of 8734 
cal/M.  Anti-8, ~, DNP-Lys8  antibody  cross-reacts  extensively  with  a,DNP- 
oligolysines.  These  cross-reactions,  however,  depend  almost  entirely  on  the H.  A.  LEVIN,  H.  LEVINE,  AND  S.  F.  SCI=ILOSSMAN  1207 
affinity for the DNP  group since  DNP-OH  contributes 93%  of the binding 
energy of ¢z,DNP-oligolysines. Since  it is possible to have contamination of 
8,e,DNP-Lys8  with  7,e,DNP-Lys~,  the  presence  of  antibody  with  7,e, 
DNP-Lys7 specificity in these animals is not unexpected. 
The  significance of  the  second peak  in  binding,  i.e.  7,e,DNP-Lys7  with 
anti-8, e, DNP-Lyss antibody, becomes clearer when the binding charactersitics 
of anti-10,e,DNP-Lysl0 and 15, e,DNP-Lys15 antibody are measured. As oc- 
curred  with  anti-8,e, DNP-Lyss  antibody,  antibody  raised  to  10,e,DNP- 
Lysl0 binds 2, ¢, DNP-Lys2 maximally. Moreover, the  --AF  ° ranged between 
8925  and 8989  cal/~ in progressing from 4,e,DNP-Lys4 to 9,e,DNP-Lys9. 
No  second  peak  is  noted  with  7,e,DNP-Lys7.  At  10,E,DNP-Lysl0  (9380 
cal/M)  and 11, e, DNP-Lysu (9385 cal/M), however, there is a  second peak  in 
binding which  corresponds  to  the  size  peptide  used  for immunization. This 
pattern of specificity is even more striking with antibody raised to 15, E,DNP- 
Lys15. Again, 2, e, DNP-Lys2 had a high binding energy of 9354 cal/M and as 
the e, DNP-oligolysine chain length is increased from 3, e, DNP-Lys3 to 12,,, 
DNP-Lys~, the binding energies are less  and range between 8110  and 8750 
cal/~. A second peak of binding energy is noted with 15,,,DNP-Lys15 (9411 
cal/~t)  and  to  a  lesser  extent  with  16,GDNP-Lys16  (9252 cal/~).  Further 
increase in peptide chain length to 18, e,DNP-Lys18 (8535 cal/~)  resulted in 
a  lower --AF  ° similar to that found for 7-13,e,DNP-LysT.I,~. As  was noted 
with antibody to 8, e, DNP-Lyss and 10, e, DNP-Lysl0, all e, DNP-oligolysines 
tested had higher affinity for anti-15, e, DNP-Lys15 antibody than did a, DNP- 
oligolysines, DNP-OH,  or DNP-EACA. 
Each  of  the  purified  antibody preparations  tested  above  showed  the  ca- 
pacity  to  discriminate  oGDNP-oligolysines  from  e,DNP-oligolysines  and 
all could distinguish within 4-  one lysyl residue the precise oligolysine chain 
length used to initiate the immune response. Despite the use of these relatively 
homogeneous antigens for immunization, the index of heterogeneity with the 
homologous immunizing antigen calculated from the Sips plot ranged between 
0.16  and 0.35. 
Skin Reactivity  and Serum Antibody  Titers of Responder and Nonresponder 
Animals Immunized with DNP-Oligolysines.--9  out of 12 NIH-Hartley strain 
guinea pigs immunized with  14, e, DNP-Lys14  in an adjuvant containing M. 
tuberculosis H37Rv responded in 2 wk with strongly positive delayed skin reac- 
tions;  the  remaining 3  animals were  completely negative. The  observed  re- 
sponder rate  of  75%  as  determined by positive delayed skin reactions  was 
similar to that obtained in this strain of guinea pigs with DNP-oligolysines in 
other adjuvants. Sera from three responders and three nonresponders to 14, e, 
DNP-Lyst4  were  used  for  subsequent  antibody  studies  and  the skin  test 
results  for  these  animals  are  shown  in  Table  II.  Camm-Hartley  guinea 
pigs were immunized in a similar fashion to the above but with ~, DNP-Lys16-30. 1208  ANTIGEN  RECOGNITION  AND  ANTIBODY  SPECIFICITY 
As expected,  4  of 12  gave a  positive delayed skin  reaction to a,DNP-Lys~G-a0 
at  2 wk; 8  had  negative  skin  reactions.  The observed responder  rate  of 33 % 
did  not  differ significantly from that  expected.  Two responder  and  two non- 
responder  animals  were  used  in  subsequent  antibody  studies  and  their  skin 
reactions are shown in Table II. 
Anti-DNP  antibody  titers  from  nonresponders  ranged between  0.124  and 
0.211 mg/ml whereas the titers for responders ranged between 0.146 and 0.247 
mg/ml  (Table  II). These results  are similar  to those obtained bv Green et at. 
(30)  and  indicate  that  irrespective  of  responder  status  all  guinea  pigs  im- 
munized with DNP-polylysines in H37Rv (10 mg/ml) produce significant levels 
of circulating anti-DNP antibody. 
TABLE II 
Titers,  ]~urified Antibody  Yield,  and  Skin  Tests  of Responder and Nonresponder Animals 
Immunized  with an Adjuvant Containing M. tuberculosis (H37Rv) 
Animal  Strain*  Antigen  Titer  Yield  Skin test*  Responder  No.  status§ 
(mg/ml)  (~7t )  (ram) 
L3  H  14, e, DNP-Lys,4  0.140  70  0  N 
L2  H  14,e, DNP-Lys~4  0.127  65  0  N 
L5  H  14,% DNP-LysI4  0.124  68  0  N 
R3  H  14,e, DNP-Lys14  0.149  60  22/20  R 
R2  H  14, ~, DNP-Lys14  0.150  60  20/20  R 
R6  H  14,e,DNP-Lys,4  0.170  65  17/16  R 
B2  C  ~, DNP-Lys,6_~0  0.211  72  +  N 
A5  C  a, DNP-Lysl~-3o  0.155  99  =t=  N 
A6  C  a, DNP-Lys,  G4o  0.146  62  25/30  R 
B3  C  a, DNP-Lys,~_~0  0. 247  82  30/30  R 
* Camm-Hartley  Strain, C; NIH Hartley,  H. 
Diameter  of induration  in millimeters, two readings 90  ° 
§ Responder, R; nonresponder, N. 
from each other at 24 hr. 
Anti-hapten  antibody  from  each  individual  animal  was  purified  for  the 
haptenic group with the insoluble absorbant DNP-HSA-cellulose and the yield 
ranged  between  60  and  99%  of  the  total  precipitable  antibody  (Table  II). 
Similar  yields were obtained from both responder  and nonresponder  animals. 
Each purified antibody was analyzed by immunoelectrophoresis against rabbit 
anti-whole  guinea pig  serum  and  rabbit  anti-guinea  pig  3'1 and  3`2  antibody. 
The purified  antibodies  were  all 3`-globulin and  consisted  of a  mixture  of  3'1 
and  3`2  globulins.  No  qualitative  differences  could  be  observed  between  the 
antibodies  elaborated  by responder  and nonresponder  animals  to  14, E, DNP- 
Lys14  and a, DNP-Lys16-3e. 
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responder Guinea Pigs.--Antibody from responder animals R2  and R6  (Figs. 
6 A  and B respectively) had maximum binding energy with 14, e, DNP-Lys14, 
the  homologous  immunizing  antigen.  The  --AF  °  for  this  interaction  were 
10,055 and 10,326 cal/•  for R2 and R6 respectively. Lengthening or shorten- 
ing of the oligolysine chain length from 14, e, DNP-Lys14 was also accompanied 
by a  significant decrease in binding energy. The high  --AF  ° for 2,e,DNP- 
Lys2 is  again noted.  Antibody raised in  responder  animal R3  (Fig.  6 C)  to 
14, e, DNP-Lys14 showed a slightly different pattern of binding. In this animal, 
both 2,e,DNP-Lys2 and 5,E,DNP-Lys5 had --AF  ° equal to or greater than 
that obtained with the homologous immunizing antigen. An  additional peak 
in binding energy is also seen with 14, E, DNP-Lys14, with a --AF  ° at least 550 
cal/M greater than that obtained with either 13, e, DNP-LySl3 or 15, e,DNP- 
Lysu. Thus,  despite  the  use  of  an  adjuvant containing H37Rv,  responder 
guinea pigs are able to elaborate at least one population of anti-DNP antibody 
which is specifically reactive with the precise chain length of the peptide used 
to induce the immune response. 
The binding characteristics of antibody raised to 14, e,DNP-Lys,4 in non- 
responder animals are shown in Figs. 6 D, E, and F. Nonresponder antibody 
showed maximum binding energy with 2, e,DNP-Lys2 and the --AF  ° for this 
interaction ranged between 9329  and 10,107 cal/M. With antibody from non- 
responder L3 and L2 (Figs. 6 D  and E)  there was no peak in binding energy 
with  14,e,DNP-Lysl~,  the homologous imnmnizing antigen.  Similarly, anti- 
body from nonresponder L5  (Fig.  6 F)  showed no specific  boost in binding 
energy  with  14,e,DNP-Lys14  but  a  slight  increase  in  --AF  °  for  10-16,e, 
DNP-LysI0.,~ peptides was noted. Of interest, and as noted with antibody raised 
in responders, dinitrophenol contributed approximately 70% of the total bind- 
ing energy, the remainder being contributed by the "oligolysine carrier." 
The specificity of anti-a,DNP-Lys16.30 antibody raised in responder Camm- 
Hartley guinea pigs A6 and B3 is shown in Figs. 7 A  and B respectively. With 
both  purified  antibody  preparations,  the  highest  --AF  °  is  obtained  with 
a,DNP-LysI6-a0,  the  homologous immunizing antigen.  The  --AF  °  for  this 
interaction ranged between 7860 and 9131 cal/~a and was 350-600 cal/M greater 
than any other interaction measured for each antibody. Of interest, the --AF  ° 
for a,DNP-Lys~ was  732-988  cal/M less  than that  obtained with a,DNP- 
Lys~8-a0 • This pattern of binding is slightly different than that obtained with 
NIH-Hartley responder  animals immunized with a,DNP-Lysle-3o  in  an  ad- 
juvant containing 2 mg/ml M.  tuberculosis (H37Ra)  and may reflect either 
genetic differences in  the  animals  or  the  use  of  an  adjuvant containing  10 
mg/ml M. tuberculosis (H37Rv)  (Fig. 2).  Both sets of experiments, however, 
show  maximum  --AF  °  with  a,DNP-Lys16-ao,  the  homologous  immunizing 
antigen. 
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guinea  pigs  with  negative  skin  tests  (Figs.  7  C  and  D)  differed  significantly 
from  that  obtained  in  responders  (Figs.  7 A  and  B).  Firstly,  a,DNP-Lys3 
exhibited,  of  all  the  peptides  tested,  the  highest  binding  energy  (9336-9961 
cal/~). Second, both nonresponder sera tested exhibited a lower binding energy 
for the homologous immunizing antigen, i.e. o~, DNP-Lys16.30, than for o~, DNP- 
Fig.  7.  The energy of binding (--AF  °) of a, DNP-Lysn peptides, n, e, DNP-Lysn peptides, 
DNP-EACA,  and dinitrophenol to anti-s,  DNP-Lysl6.~0  antibody raised in responder and 
nonresponder Hartley strain guinea pigs.  A  and B  are responder animals A6 and B3 respec- 
tively. C and D are nonresponder animals B2 and A5 respectively. 
Lys~.  Finally,  there  is  no  peak  in  binding  energy  for ot,DNP-Lys16-z0,  i.e., 
nonresponder  antibody could not discriminate  ot,DNP-Lysl6_30  from ot,DNP- 
Lys15 or a, DNP-Lys~o-lo0. 
DISCUSSION 
Present  studies  indicate  that  the  antibody-forming  cell  has  the  capacity 
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group, the position of the haptenic group, and the number of lysyl residues on 
the oligolysine chain used to induce the immune response. The data presented 
demonstrate  that  antibody  raised  to  a,DNP-LysT.lo  in  responder  animals 
can be readily distinguished from that produced to a, DNP-LySl6-30,  and simi- 
larly  antibodies  formed  to  8,e,DNP-Lyss,  10,e,DNP-Lys10,  14,e,DNP- 
Lys14, and 15, e, DNP-Lysl~ are readily discriminated. 
Although  an upper limit for the size of an antibody-binding site has been 
estimated in several systems (6, 9,  18-20,  38), much less is known about the 
conformation of  the  antigenic  determinant  and  its  influence on  the  dimen- 
sions  and  specificity of the  binding  site.  If we  accept  the  premise that  the 
antibody-binding site has a limited size or volume of about 7 residues or less, 
the addition of lysines to a, DNP-LysT-lo or 8, e, DNP-Lyss must result in com- 
pounds which  are  distinguished by antibody because of changes in the  con- 
formation of the lysines adjacent to the DNP group. Thus, we conclude that 
each immunogenic peptide possesses  a  preferred conformation or set  of con- 
formations that are recognized by the immunologically competent cell and that 
such cells have the capacity to elaborate a population of antibody molecules 
that  can repeatedly distinguish  the  homologous immunizing  antigen  4-  one 
lysyl residue.  Previous estimates  of the  size  of the  antibody-combining site 
have been based on data supplied by a series of antibody-hapten interactions 
(quantitative inhibition of precipitation, equilibrium dialysis, and fluorescence 
quenching).  It  is  now apparent  that  the  lack  of rigidity of the  peptides  or 
hapten-peptide conjugates places certain limitations on their use as measuring 
sticks. Just as it is unreasonable to suggest that anti-a, DNP-Lyst6.~0 antibody 
has a  binding site  16-30 residues long, it is  equally difficult to decide on an 
upper limit  in  site  size  of 7  residues without precise knowledge of the  con- 
formation of the antigenic determinant used for immunization and the fragment 
used to define the site. 
The present data do not, however, permit us to estimate what percentage 
of the antibody is made to these "preferred sets of conformations." Moreover, 
if the antibody-forming apparatus can detect a preferred set of conformations, 
it is likely to respond to minor conformations of antigen in association with 
host protein or with the mycobacteria present in the adjuvant. The latter inter- 
actions may account for the heterogeneity of antibody as measured by the in- 
dex of heterogeneity (a)  in the Sips plot.  Similarly,  others have shown that 
single  determinant haptenic  antigens  do not  necessarily evoke homogeneous 
antibody responses  (39-41). 
The present studies confirm the observations of Green et al. demonstrating 
that responder guinea pigs developed delayed hypersensitivity and anti-DNP 
antibody when  immunized with  DNP-polylysines in an adjuvant containing 
M. tuberculosis H37Rv (30). Under these experimental conditions, nonresponder 
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velop delayed skin reactivity or its in vitro correlates. Detailed analysis of the 
specificity of purified antibodies to a, DNP-Lys16.30 and 14, ~, DNP-Lys14 from 
both responder and nonresponder animals shows that the antibodies produced 
are different. The antibodies of all responder animals distinguish  the precise 
DNP-oligolysine  chain  length  used  to  induce  the  immune  response  4-  one 
lysyl residue as reflected by a  greater  --AF  ° for the interaction of antibody 
with the homologous immunizing antigen than for its interactions with others. 
Antibody made by nonresponder animals to the identical antigens, in contrast, 
shows no greater --AF  ° with the homologous immunizing antigen and cannot 
distinguish  the precise DNP  oligolysine chain length used to induce the im- 
mune response. Although these differences permit distinction between responder 
and  nonresponder antibody,  it is  still  not known  what  fraction of the  total 
antibody produced in the responder is directed at the precise DNP-oligolysine 
chain length used to induce the immune  response.  In the nonresponder, we 
presume,  however,  that  interaction  of  DNP-polylysines with  the  adjuvant 
generates  the  antigenic  determinant  and  that  anti-hapten  antibody-forming 
cells in the nonresponder recognize and respond not only to the DNP-polylysines 
but  to portions  of the  adjuvant  as well.  More important,  providing an im- 
munogenic carrier for DNP-polylysines in the form of large amounts of H37Rv 
does  not  circumvent  the  genetically deficient  recognition  step  in  the  non- 
responder. If it did, the antibody formed to DNP polylysines in both groups of 
animals would have been identical. Evidently the polylysine gene also controls 
directly an  antibody-forming system  which can recognize the total  antigenic 
determinant used to induce the immune response rather than  only a  carrier- 
specific cell which functions early in the immune response to present a  non- 
immunogenic  haptenic  portion  of  a  molecule  to  an  anti-hapten  antibody- 
forming  cell.  These  observations  are  in  keeping  with  a  local  environment 
hypothesis  for  antigen  recognition  by  the  antibody-forming  cell  (42).  An 
alternative but less likely site of action of the PLL gene is at the carrier-specific 
cell, early in the immune response, controlling the manner in which antigen is 
presented to the anti-hapten  antibody-forming cell (24). Under such circum- 
stances D NP-oligolysine with H37Rv would affect  the selection of the antibody- 
producing  cell precursors  in  such  a  way  that  the  antibody produced in  re- 
sponders  and  nonresponders  would  be  different,  despite  the  fact  that  both 
responders  and  nonresponders  had  an  identical  complement of  anti-DNP- 
polylysine antibody-forming cells.  It would be difficult to test for the latter 
possibility. 
It is implicitly assumed by many immunologists that anti-hapten antibody 
is directed at the haptenic group alone and that the heterogeneity of antibody 
results from the multiplicity of responses to the haptenic group alone by the 
antibody-forming apparatus.  In the present study we have shown that  anti- 
hapten antibody purified with cross-reactive DNP-HSA-cellulose has  carrier 1214  ANTIGEN  RECOGNITION  AND  ANTIBODY  SPECIFICITY 
specificity which is a  function of the local chemical environment surrounding 
the haptenic group. The extent of the carrier specificity observed with anti- 
DNP-oligolysine antibody raises  certain questions about  the mechanism  by 
which antibody is generated. In this regard,  it has been shown that cellular 
cooperation occurs during the induction of the immune response (43-47)  and 
that individual cells separately recognize carrier and haptenic portions of the 
antigen (14-17).  The present studies indicate that the antibody-forming cell 
has an extraordinary degree of carrier specificity as measured by its capacity 
to elaborate a highly specific antibody molecule. Does the carrier-specific cell 
have an equivalent degree of carrier specificity and, if so,  how can  two  such 
highly specific cells seek one another out to cooperate in antigen recognition? 
Alternatively, is  the  carrier-specific  helper  cell  merely "oligolysine-specific" 
and capable of focussing DNP-polylysines on a wide variety of hapten-specific 
antibody-forming cells  which  recognize  both  the  hapten  and  the  adjacent 
carrier? While the evidence for cellular cooperation in the generation of antibody 
is impressive, the mechanism by which two cells cooperate in the recognition 
of an antigen by either of the above or still other schemes is obscure. 
Finally, it is widely held that antibody synthesis is initiated by selection by 
the  antigen  of  a  population of cells  with complementary and  stereospecific 
receptors  identical to  the  antibody molecule subsequently produced.  In  the 
present studies each DNP-oligolysine used induces at least one population of 
antibody molecules unique unto itself. Conservatively one could estimate that 
there preexist 20 separate antibody populations for the n, e, DNP-Lysn peptides 
and a similar number for the a,DNP-Lysn series. Moreover, it was shown that 
anti-5, ~,DNP-Lys9 antibody was specific  (48),  and a further extrapolation of 
this observation suggests that an additional 20 antibody populations may be 
generated by DNP  groups on different e,amino positions of the lysine chain. 
Thus, using a  simple hapten on an oligolysine backbone of variable size, one 
could  generate  a  minimum of  60  different antibody populations:  100-1000 
may not be unrealistic. Probably, the oligolysine backbone in conjunction with 
another haptenic group  such  as penicilloyl would induce  additional sets  of 
antibody molecules  (49).  Given the hundreds of such haptens available,  the 
minimal number of antibodies generated by the simplest synthetic immunogen- 
hapten complex could easily reach 104-105 separate molecules. Very likely, the 
degree of antibody specificity described in the present paper would occur with 
other  synthetic  polypeptide  antigens  as  well  as  with  naturally  occurring 
antigens. The quantity of preexisting information required to account for the 
specificity of antibody is difficult to understand in terms of a germ line theory 
(50)  and may be more compatible with theories depending on somatic muta- 
tion,  recombination,  or  episomal  insertion  (51-56).  The  high  specificity of 
antibody observed in these experiments demands an immune system capable 
of recognizing subtle changes in antigen and probably one more complex than 
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SUMMARY 
The exact specifiicity  of anti-DNP  antibody produced by Hartley guinca 
pigs immunized with a series  of defined o~,DNP  and e,DNP-oligolysines  was 
studied by fluorescence quenching.  All responder  animals  made  anti-DNP 
antibody which recognized the precise  chain length, -4- 1 lysyl  residue,  of the 
DNP-oligolysines  used to induce  the immune  response as measured  by an 
increase  in binding energy (--AF  °) for that antigen.  The ability  of the immune 
system to  detect  the smallest  possible  change in  oligolysine  chain  length suggests 
that the anti-hapten antibody-forming  cell  possesses a highly specific  recogni- 
tion system for carrier  conformation. When DNP-oligolysines  are incorporated 
in an adjuvant containing M. tuberculosis  H37Rv,  both responder  and non- 
responder produce anti-DNP antibody, but only the  responder develops delayed 
skin  sensitivity.  In addition  to their  failure  to develop delayed hypersensitivity, 
nonresponders  produced antPDNP  oligolysine  antibody which did not show 
the increase  in --AF  ° for the immunizing antigen characteristic  of responder 
antibody.  These  observations support  a local environment  hypothesis  for 
antigen recognition at the level of the anti-hapten antibody-forming  cell  and 
suggest that the polylysine  gene exerts  its  control  at the same cell. 
REFERENCES 
1.  Burnet,  F. M.  1959. The Clonal Selection Theory of Acquired Immunity. Cam- 
bridge University Press, Cambridge, England. 
2.  Jerne, N. K. 1960. Immunological speculations. Annu. Rev. Microbiol. 14:341. 
3.  Eisen, H. N., J. R. Little, L. A. Steiner,  E. S. Simms, and W. Gray.  1969. De- 
generacy in the secondary immune response: stimulation of antibody formation 
by cross-reacting antigens. Israel J. Med. Sci. 5:338. 
4.  Siskind,  G. W., and B. Benacerraf. 1969. Cell selection by antigen in the immune 
response. Advan. Immunol. 10ft. 
5.  Lenox, E., and M. Cohn. 1967. Immunoglobulins. Annu. Rev. Biochem. 36:365. 
6.  Levin, H. A., H. Levine, and S. F. Schlossman. 1970. Studies on the specificity and 
affinity of a,DNP-oligolysine antibody: a basis for questioning the role of cell 
bound antibody in cellular recognition of antigen. J. Immunol. 104:1377. 
7.  Ovary, Z.,  and  B.  Benacerraf.  1963. Immunologic specificity  of  the  secondary 
response with dinitrophenylated proteins. Proc. Soc. Exp. Biol. Mecl. 114:72. 
8.  Gell, P. G. I-I., and B. Benacerraf. 1961. Delayed hypersensitivity to simple protein 
antigens. Advan. Immunol. 1:319. 
9.  Schlossman, S. F., and H. Levine. 1967. Immunochemical studies on delayed and 
Arthus-type hypersensitivity reactions: I. The relationship  between antigenic 
determinant size and antibody combining site size. J. Immunot. 98:211. 
10.  Dutton, R. W., and H. N. Bulman. 1964. The significance  of the protein carrier in 
stimulation of DNA synthesis by hapten-protein conjugates in the secondary 
response. Immunology. 7:54. 
11.  Stulbarg,  M.,  and  S.  F.  Schlossman.  1968. The  specificity  of  antigen-induced 
thymidine-2-14C  incorporation into lymph node cells from sensitized  animals. 
J. Immunol. 101:764. 1216  ANTIGEN RECOGNITION  AND  ANTIBODY  SPECIFICITY 
12.  Paul, W. E., G. W. Siskind, and B. Benacerraf. 1968. Specificity of cdlular immune 
responses: antigen concentration dependence of stimulation of DNA synthesis in 
vitro by specifically sensitized cells, as an expression of the binding characteris- 
tics of cellular antibody. J. Exp. Med. 19.7:25. 
13.  Schlossman, S. F., and H. Levine. 1970. The specificity of the secondary immune 
response: characterization of the antibody produced to cross reactive antigens. 
Cell. Immunol.  1:419. 
14.  Mitchison, N. A.  1970. In  Mediators of  Cellular Immunity.  H.  S.  Lawrence 
and M. Landy, editors. Academic Press, Inc., New York.  73. 
15.  Rajewsky, K., V. Schirrmacher, S. Nase, and N. K. Jerne. 1969. The requirement 
of more than one antigenic determinant for immunogenicity. J. Exp. Med. 129: 
1131. 
16.  Katz, H., W. E. Paul, E. H. Goidl, and B. Benacerraf. 1970. Carrier function in 
anti-hapten immune responses. I. Enhancement of primary and secondary anti- 
hapten antibody responses by carrier preimmunization. J. Exp. Med. 132:261. 
17.  Bretscher, P., and M. Cohn. 1970. A theory o[ self-non self discrimination. Science 
(Washington). 169:1042. 
18.  Kabat, E. A. 1966. The nature of an antigenic determinant. J. Immunol. 97:1. 
19.  Sela, M.  1969. Antigenicity: some molecular aspects. Science (Washington). 166: 
1365. 
20.  Schlossman, S. F., H. Levine, and A. Yaron. 1968. Studies on the specificity of anti- 
body to 2,4-dinitrophenyl-poly-L-lysines.  Biochemistry. 7:1. 
21.  Levine, B. B., A. Ojeda, and B. Benacerraf. 1963. Studies of artificial antigens. III. 
The genetic control of the immune response to hapten-poly-L-lysine conjugates 
in guinea pigs. J. Exp. Med. 118:953. 
22.  Levine, B. B., and B. Benacerraf. 1965. Genetic control in guinea pigs of immune 
response  to  conjugates  of  haptens  and  poiy-L-lysine. Science (Washington). 
147:517. 
23.  Benacerraf, B., I. Green, and W. E. Paul. 1967. The immune response of guinea 
pigs to hapten poly-L-lysine conjugates as an example of the genetic control of 
the recognition of antigenicity. Cold Spring Harbor Syrup. O  uant. Biol. 32:569. 
24.  McDevitt, H. O., and B. Benacerraf. 1969. Genetic control of the specific immune 
response. A dvan. Immunol. 11:31. 
25.  Green, I., W. E.  Paul, and B. Benacerraf.  1966. The behavior of hapten-poly-L- 
lysine conjugates as complete antigens in genetic responder and as haptens in 
nonresponder guinea pigs. J. Exp. Med. 123:859. 
26.  Schlossman,  S.  F., A. Yaron,  S. Ben-Efraim,  and H.  A. Sober.  1965. Immuno- 
genicity of a series of a, N-DNP-L-Lysines. Biochemistry. 4:1638. 
27.  Schlossman, S. F., J. Herman, and A. Yaron. 1969. Antigen recognition: in vitro 
studies on the specificity  of the cellular immune response. J. Exp. Med. 130:1031. 
28.  Eisen,  H.  N.  1964. Preparation  of  purified  anti-2,4-dinitrophenyl antibodies. 
Methods Med. Res. 10:94. 
29.  Robbins, J. B., J. Haimovich, and M. Sela. 1967. Purification of antibodies with 
immunoabsorbants  prepared  using  bromoacetyl  cellulose.  Immunoehemistry. 
4:1. 
30.  Green, I., B. Benacerraf, and S. Stone. 1969. The effect of the amountof mycobac- It.  A.  LEVIN,  H.  LEVINE, AND  S.  F.  SCItLOSSMAN  1217 
terial adjuvants on the immune response of strain 2,  strain  13,  and Harfley 
strain guinea pigs to DNP-PLL and DNP-GL. J. Immunol. 103:403. 
31.  Farah, F. S., M. Kern, and H. N. Eisen. 1960. The preparation and some properties 
of purified antibody  specific for  the  2,4-dinitrophenyl group.  J.  Exp.  Med. 
112:1195. 
32.  Velick, S. F., C. W. Parker, and H. N. Eisen, 1960. Excitation energy transfer and 
the quantitative study of the antibody hapten reaction. Proc. Nat.  Acad.  Sei. 
U.S.A. 46:1470. 
33.  Eisen, H. 1964. VII. Determination of antibody affinity for haptens and antigens 
by means of fluorescence quenching. Methods Med. Res. 10:115. 
34.  Eisen,  H.  1964.  VI.  Equilibrium  dialysis for measurement  of antibody-hapten 
affinities. Methods Med. Res. 10:106. 
35.  Sips, R. 1950. On structure of a catalyst surface. J. Chem. Phys. 18:1024. 
36.  Nisonoff, A., and D.  Pressman.  1958.  Heterogeneity of average combining con- 
stants of antibodies from individual rabbits. J. Immunol. 80:417. 
37.  Paul, W. R., G. W. Siskind, and B. Benacerraf. 1966. Studies on the effect of the 
carrier molecule on anti-hapten antibody synthesis. II.  Carrier specificity of 
anti-2,4-dinitrophenyl-poly-L-lysine  antibodies. J. Exp. Med. 123:689. 
38.  Schechter, B., I. Schechter, and M. Sela. 1970. Antibody combining sites to a series 
of peptide determinants of increasing size and defined structure. J. Biol. Chem. 
245:1438. 
39.  Eisen, H. N., E. S. Simms, J. R. Little, Jr., and L. A. Steiner. 1964. Affinities of 
anti-2,4-dinitrophenyl (DNP)  antibodies induced by  e,  41  mono-DNP-ribo- 
nuclease. Fed. Proc. 9.3:559. 
40.  Haber,  E.  1968.  Immunochemistry.  Annu.  Rev.  Biochem.  37:497. 
41.  Little, J.  R., and  R.  B.  Counts.  1969. Affinity and heterogeneity of antibodies 
induced by e,2,4-dinitrophenyl insulin. Biochemistry. 8:2729. 
42.  Mitchison, N. A. 1967. Antigen recognition responsible for the induction in vitro 
of the secondary response.  Cold  Spring Harbor  Symp.  Quant.  Biol.  39.:431. 
43.  Claman, H. N., E. A. Chaperon, and R. F. Triplett. 1966. Thymus-marrow cell 
combinations. Synergism in antibody production. Proc. Soc.  Exp.  Biol.  Med. 
19.2:1167. 
44.  Davies, A. J.  S., E. Leuchars, V. Wallis, R. Marchant, and E. V. Elliott. 1967. 
The failure of thymus-derived cells to produce antibody. Transplantation. 5:222. 
45.  Miller, J. F. A. P., and G. F. Mitchell. 1968. Cell to cell interaction in the immune 
response.  I.  Hemolysin-forming cells in  neonatally thymectomized  mice  re- 
constituted with thymus or thoracic duct lymphocytes. J. Exp. Med. 128:801. 
46.  Mitchell, G. F., and J. F. A. P. Miller. 1968. Cell to cell interaction in the immune 
response. II. The  source of hemolysin-forming cells in irradiated mice given 
bone marrow and thymus or thoracic duct lymphocytes. J. Exp. Med. 128:821. 
47.  Taylor, 1%. B. 1969. Cellular cooperation in the antibody response of mice to two 
serum albumins: specific function of thymus cells. Transplant. Rev. 1:114. 
48.  Schlossman, S. F., and A. Yaron. 1970. Immunochemical studies on the specificity 
of  cellular and  antibody-mediated immune  reactions.  Ann.  N.Y.  Acad.  Sei. 
169:108. 
49.  Levine, B. B.,  A. Ojeda, and B. Benacerraf.  1963. Basis for the antigenicity of 1218  ANTIGEN RECOGNITION AND ANTIBODY SPECIFICITY 
hapten-poly-L-lysine conjugates in random-bred guinea pigs. Nature  (London). 
200:544. 
50.  Hood, L.,  and D. W. Talmage.  1970. Mechanisms of antibody diversity:  germ 
line basis for variability. Science  (Washington). 168:325. 
51.  Edelman, G. M., and M. Gally. 1967. Somatic recombination of duplicated genes: 
an hypothesis on the origin of antibody diversity. Proc. Nat. Acad. Sci. U.S.A. 
57:353. 
52.  Potter, M., E. Appella, and S. Geisser.  1965. Variations in the heavy polypeptide 
chain structure of gamma myeloma immunoglobulins from an inbred strain of 
mice and a hypothesis as to their origin. J. Mol. Biol. 14:361. 
53.  Burner, M. 1966. A possible  genetic basis for specific pattern in antibody. Nature 
(London). 210:1308. 
54.  Brenner, S., and C. Milstein.  1966. Origin of antibody variation. Nature (London). 
211:242. 
55.  Dreyer, W. J., and J. C. Benett. 1965. The molecular basis of antibody formation: 
a paradox. Proc. Nat. Acad. Sci. U.S.A. 54:864. 
56.  Wu, T. T,, and E. A. Kabat.  1970. An analysis of the sequences of the variable 
regions of Bence Jones proteins and myeloma light chains and their implications 
for antibody complementarity. J. Exp. Med. 132:211. 